Tert-butyl N-[3-[6-(3-chloro-4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]oxycyclobutyl]carbamate
C27H32ClN3O5 — CID 162752504
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[3-[6-(3-chloro-4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]oxycyclobutyl]carbamate
Tert-butyl N-[3-[6-(3-chloro-4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]oxycyclobutyl]carbamate (PubChem CID 162752504) has the molecular formula C27H32ClN3O5 and a molecular weight of 514.02 g/mol. Its IUPAC name is tert-butyl N-[3-[6-(3-chloro-4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]oxycyclobutyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[3-[6-(3-chloro-4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]oxycyclobutyl]carbamate |
|---|---|
| PubChem CID | 162752504 |
| Molecular Formula | C27H32ClN3O5 |
| Molecular Weight | 514.02 g/mol |
| Exact Mass | 513.20 |
| IUPAC Name | tert-butyl N-[3-[6-(3-chloro-4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]oxycyclobutyl]carbamate |
| SMILES | CC(C)(C)OC(=O)NC1CC(Oc2cc(-c3ccc(O)c(Cl)c3)cc3c2cnn3C2CCCCO2)C1 |
| InChI | InChI=1S/C27H32ClN3O5/c1-27(2,3)36-26(33)30-18-13-19(14-18)35-24-12-17(16-7-8-23(32)21(28)10-16)11-22-20(24)15-29-31(22)25-6-4-5-9-34-25/h7-8,10-12,15,18-19,25,32H,4-6,9,13-14H2,1-3H3,(H,30,33) |
| InChIKey | JDOZLJDOUYKMSI-UHFFFAOYSA-N |
| XLogP | 6.20 |
| TPSA | 94.84 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 514.02 |
| LogP ≤ 5 | 6.20 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162752504 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.